SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011686
Filing Date
2021-05-17
Accepted
2021-05-17 08:30:42
Documents
54
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 407652
2 ex10-1.htm EX-10.1 402533
3 ex31-1.htm EX-31.1 18823
4 ex31-2.htm EX-31.2 18872
5 ex32-1.htm EX-32.1 10431
6 ex32-2.htm EX-32.2 11034
  Complete submission text file 0001493152-21-011686.txt   2485474

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE sonn-20210331.xml EX-101.INS 231041
8 XBRL SCHEMA FILE sonn-20210331.xsd EX-101.SCH 28097
9 XBRL CALCULATION FILE sonn-20210331_cal.xml EX-101.CAL 40577
10 XBRL DEFINITION FILE sonn-20210331_def.xml EX-101.DEF 95153
11 XBRL LABEL FILE sonn-20210331_lab.xml EX-101.LAB 188641
12 XBRL PRESENTATION FILE sonn-20210331_pre.xml EX-101.PRE 157217
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35570 | Film No.: 21927756
SIC: 2834 Pharmaceutical Preparations